<DOC>
	<DOC>NCT02808299</DOC>
	<brief_summary>The purpose of this study is to investigate the incidence of liver injury by statins in coronary heart disease (CHD) patients with history of hepatitis B virus (HBV) infection.</brief_summary>
	<brief_title>Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Encephalitis, Herpes Simplex</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>patients with CHD receive longterm statin treatment ALT is over ULN at baseline infection of Hepatitis A Virus, Hepatitis C Virus or Hepatitis E Virus triglyceride is over 4.5 mmol/L decompensated liver cirrhosis (Child B or C) active stage of HBV infection of Burkitt's lymphoma virus or cytomegalovirus, or other acute infectious disease congestive heart failure malignant tumor autoimmune disease receive other potential hepatotoxicity drugs such as immunosuppressant, antituberculotic and nonsteroid antiinflammatory drug.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>statin</keyword>
	<keyword>hepatitis B virus</keyword>
</DOC>